RedHill Biopharma (RDHL) Prepaid Assets (2011 - 2025)
RedHill Biopharma's (RDHL) quarterly Prepaid Assets came in at $2.5 million in Q4 2025, up 124.46% year-on-year from $1.1 million in Q4 2024, and up 145.35% on a QoQ basis from $1.0 million in Q2 2025.
RedHill Biopharma (RDHL) Prepaid Assets (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has 15 years of Prepaid Assets data on file, last reported at $2.5 million in Q4 2025.
- On a quarterly basis, Prepaid Assets rose 124.46% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 124.46% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 124.46% from the prior year.
- Prepaid Assets for Q4 2025 stood at $2.5 million, up from $1.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for RDHL reached as high as $5.2 million in Q1 2023 and fell as low as $1.0 million in Q2 2025.
- Historically, Prepaid Assets has averaged $3.3 million across 5 years, with a median of $3.3 million in 2022.
- Across the five-year window, Prepaid Assets jumped 155.24% in 2021 and slumped 65.28% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $4.7 million in 2021, then dropped by 5.88% to $4.4 million in 2022, then tumbled by 36.15% to $2.8 million in 2023, then tumbled by 60.59% to $1.1 million in 2024, then surged by 124.46% to $2.5 million in 2025.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.5 million in Q4 2025, $1.0 million in Q2 2025, and $1.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.48 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 5.17 Mn |
| Dec 31, 2022 | 4.39 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 4.66 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Mar 31, 2021 | 4.09 Mn |
| Dec 31, 2020 | 5.52 Mn |
| Sep 30, 2020 | 4.64 Mn |
| Jun 30, 2020 | 4.87 Mn |
| Mar 31, 2020 | 1.60 Mn |
| Dec 31, 2019 | 2.24 Mn |